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INTRODUCTION
Biliary atresia is a neonatal obstructive cholangiopathy char-
acterized by progressive obliteration or discontinuity of the
extrahepatic bile duct. The obstruction of bile flow results in
worsening cholestasis, hepatic fibrosis, and cirrhosis, which
lead to portal hypertension and a decline in hepatic synthet-
ic function. Biliary atresia is the leading indication for liver
transplantation in children (1, 2).
In fact, little is known about the etiology of this disorder,
so it would be very meaningful to identify genes that are specif-
ically expressed in liver tissue caused by biliary atresia and
analyze the pattern of expression of those genes. This would
lead to a better understanding of the pathogenesis as well as
developing methods of early detection.   
Recently, several studies have been done to find out specif-
ic gene expression. Malizia et al. suggested that transforming
growth factor (TGF)  1 and platelet-derived growth factor
(PDGF) are involved in human liver inflammation and fibro-
sis, so that the expression of growth factor mRNAs in pro-
liferating ductular cells may indicate a role for these cells in
liver fibrogenesis and may help explain the pathophysiology
of conditions such as biliary atresia progressing to fibrosis
despite the absence of marked inflammation (3, 4). 
The pattern of expression of genes may be more informative
than analysis of a few individual genes. Therefore, we studied
the gene expression difference in biliary atresia liver tissues
compared to normal liver tissues, which were obtained main-
ly from living related liver transplantation, to understand the
pathogenesis and to analyze the pattern of gene expression in
biliary atresia by using a dot blot panel of 1,730 different
expressed sequence tags (ESTs) clones which were isolated
from a human hair dermal papilla cell cDNA library in
Kyungpook National University (KNU).
MATERIALS AND METHODS 
Human cDNA clone
The cDNA library was constructed with mRNA from
human dermal papilla cells. Inserts (>400 bp) were unidirec-
tionally cloned into the lambda Uni-Zap phage vector to gen-
erate 10
7-10
8 recombinants. Bacterial transformants were ob-
tained by cotransfection with a helper Sequena phage. Colonies
were picked at random and minilysate DNA was prepared
by alkaline lysis using REAL preps (Qiagen, Hilden, Ger-
many). cDNA was sequenced from 5 end of the insert using
a Sequenase DNA sequencing kit. Sequences were compared
with GenBank database.
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Biliary atresia is a progressive obliterative cholangiopathy, but the etiology of this
disorder remains uncertain. Identifying genes specifically expressed in biliary atre-
sia and analyzing the pattern of expression may lead to a better understanding of
the pathogenesis. Liver tissues were taken from a recipient with biliary atresia
and a normal donor during liver transplantation. Total RNA was extracted from
each sample and reversely transcribed to cDNA. Then radiolabeled cDNA probe
pools were made by random primed DNA labeling method and used for screen-
ing of differentially expressed genes by hybridizing with expressed sequence tags
(EST) dot blot panel. Northern blot hybridization was done to confirm that these
genes are also differentially expressed in other liver tissues. Among 1,730 EST
clones, 26 cDNA clones were significantly overexpressed in biliary cirrhosis, while
2 clones were significantly decreased in biliary atresia. By Northern blot hybridiza-
tion, the results of tissue inhibitor of metalloproteinase (TIMP)-1 and IGFBP-2 were
well correlated with differential EST screening (DES). This study identified the pat-
tern of differentially expressed genes in the biliary cirrhosis due to biliary atresia
using DES technique.
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cDNA array preparation
A total of 1,730 cDNAs were arrayed in nylon membranes
using 96-well format dot blotter (BioRad, Hercules, CA,
U.S.A.). Two identical blots were produced for each set of
cDNA samples. Briefly, the membranes were cut to the size
of the dot blot manifold and soaked in 0.4 M Tris (pH 7.5)
for 5 min. The membrane was placed into the manifold and
clamped. The plasmid DNAs were denatured for 10 min at
room temperature in 0.25 N NaOH/0.5 M NaCl. The DNAs
were diluted in 0.1 SSC/0.125 N NaOH so that 200 ng
DNA was fixed per dot. The DNA samples were loaded into
the manifold and suction was applied. The membranes were
removed from the manifold, neutralized by rinsing in 0.5
M NaCl/0.5 M Tris (ph 7.5) air dried, and then fixed by UV
crosslinking at 240 mJ using a Stratalinker (Stratagene, La
Jolla, CA, U.S.A.).
Preparation of RNA from biliary atresia and normal
liver tissues
Liver parenchymal tissues from 5 biliary atresia patients and
3 normal controls were put into liquid nitrogen immediate-
ly after resection to avoid RNA degradation during living
related liver transplantation and liver operation. Total RNA
was extracted from one hundred milligrams of pulverized tis-
sues by a modified acid guanidinium thiocyanate/phenol/
chloroform extraction method (Chomczynski & Sacchi, 1987)
using TRIzol (Life Technologies, Bethesda, U.S.A.). 
Preparation of probe and hybridization 
The cDNAs to be used as probes were synthesized from
total RNAs prepared from biliary atresia and normal liver
tissues, using an oligo (dT) primer and Superscript II reverse
transcriptase. The cDNA was radiolabeled with 
32P-dCTP
by random priming. Equal counts of the probes were heat-
denatured and used to probe the DNA dot blots in Express-
Hyb Hybridization Solution.
Films were scanned with Epson GT-8500 scanner and den-
sity of each dot was measured using public domain NIH
Image program. Density was calculated by integration of the
values of pixels of each dot. The ratio of density of each dot
between biliary atresia and normal control was calculated and
the ratio over 1.5 was arbitrarily counted as significantly
increased, just for screening (Table 1). 
Northern blotting
Northern blotting was done to confirm those clones differ-
entially expressed in the differential EST screening. Five
infants (4 recipients of liver transplantation around 1 yr of
age and 1 from Kasai portoenterostomy operation around 10
weeks of age) with extrahepatic biliary atresia and 3 controls
(2 normal donor livers and 1 normal portion of liver in a hep-
atocellular carcinoma patient) were studied. 10  g of total
RNA prepared from normal and biliary atresia liver tissues
were used. 
RESULTS
Among the total of 1,730 EST clones, 26 cDNA clones were
significantly overexpressed in biliary cirrhosis due to biliary
atresia. They were sorted by the classification of cDNA library
in KNU (http://hair.knu.ac.kr/ebtoc.htm) and revealed homol-
ogy to genes encoding (Table 1):
1) Cell division/DNA synthesis related: bcl-w. 2) Cell signal-
ing and communication related: laminin binding protein (BP),
hepatocyte growth factor-regulated tyrosine kinase substrate
(HRS), thymosin -4, 10, TGF- . 3) Gene/protein expression
Bcl-w 16.7 28.8 1.7
Laminin BP (binding protein) 0.7 7.7 11
HRS (HGF-regulated tyrosine 
kinase substrate) 0.5 3.5 6.9
Thymosin -4 0.6 4.1 6.5
Thymosin -10 0.5 2.5 5.4
TGF- 0.6 2.1 3.3
TIMP (tissue inhibitor of 
metalloproteinase)-1 1.8 3.9 2.2
SRP (signal recognition particle) 4 2 7.1 3.6
SRP9 1.7 5.6 3.3
SNAP (soluble NSF 
attachment proteins) 45 1.2 5.6 4.5
Alu RNA BP 0.8 6.9 8.5
supt5h (human homologue of 
the yeast transcription factor, SPT5) 1.9 4.5 2.3
eIF-2 kinase 4.5 12.1 2.7
HSP (heat shock protein) 27 2.1 3.7 1.8
Lysyl oxidase 10.8 22.2 2.1
MLC (myosin light chain) kinase 12 37.2 3.1
Aldolase A 29.4 57.3 1.9
-glutamylcystein synthetase 17.3 45 2.6
Collagen type I 1  1.5 10.1 6.8
Collagen type I 2 1.1 9.4 8.7
Collagen type III 3 8.5 2.9
Fibronectin 1.5 7.3 4.9
Osteonectin 3.3 5.8 1.8
IGFBP (insulin-like growth 
factor binding protein)-2 1.7 6.1 3.6
IGFBP (insulin-like growth 
factor binding protein)-3 5.7 8.3 1.5
Pentaxin 3 1.9 4.5 2.4
Gastrula zinc finger protein* 14.5 2.2 6.6
-1
A novel gene: K0059*   8.5 1.4 6.1
-1
*: genes of which the expression was decreased.
Transcript identity
Table 1. Differential profile of differentially expressed genes identi-
fied in DES
Intensity     Ratio (BA/ 
Normal) Normal             BA394 B.H. Choe, K.M. Kim, S. Kwon, et al.
related: tissue inhibitor of metalloproteinase (TIMP)-1, sig-
nal recognition particle (SRP)4, SRP9, soluble NSF attach-
ment proteins (SNAP)45, Alu RNA BP, supt5h (human ho-
mologue of the yeast transcription factor, SPT5), eukaryotic
initiation factor (eIF)-2 kinase. 4) Cell/organism defence and
homeostasis related: heat shock protein (HSP)27. 5) Metabo-
lism related: lysyl oxidase, myosin light chain (MLC) kinase,
aldolase A,  -glutamylcysteine synthetase. 6) Cell structure
and motility related: collagen type I 1, 2, collagen type III,
fibronectin, osteonectin. 7) unclassified: insulin-like growth
factor binding protein (IGFBP)-2, 3, pentaxin 3. 
The expressions of 2 clones were significantly decreased
in biliary atresia, which were gastrula zinc finger protein
and one novel gene (Fig. 2).
Northern blot hybridization confirmed that TIMP-1 and
IGFBP-2 were significantly overexpressed in biliary cirrho-
sis due to biliary atresia (Fig. 3).
DISCUSSION
Proposed mechanisms of the pathogenesis of biliary atresia
include occult viral infection, toxin, defect in morphogenesis,
disorder of immunologic/inflammatory system, and defect in
fetal/perinatal circulation. Therefore, biliary atresia is suggest-
ed to be a heterogeneous disorder and a common phenotype
of several different disorders (2).
It is important to find genes specifically expressed in liver
cells of biliary atresia in order to study biologic properties of
biliary cirrhosis due to biliary atresia. Comparing expression
Fig. 1. Flow diagram of the differential expressed sequence tags
screening (DES) technique (EST: Expressed Sequence Tags, BA:
biliary atresia).
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Fig. 2. Results of DES in normal liver and biliary atresia liver tissues. EST dot blot panels were hybridized in ExpressHyb hybridization solu-
tion (Clontech, USA) with radioactive cDNA probe pools at the concentration of 2 10
6 cpm/mL at 68 for 1 hr. After hybridization, mem-
branes were washed in 2 SSC/0.05% SDS at room temperature for 40 min with two changes, followed by washes in 0.1 SSC/0.1% SDS
for 40 min with one change. Then the membranes  were wrapped and exposed to X-ray film at -70 for 3 weeks. Arrows indicate differ-
entially expressed genes.
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Fig. 3. Northern blot analysis of 2 out of 28 genes of which the ex-
pression was shown to be altered in differential EST screening.
Each 10  g of total RNA was electrophoresed on 1% gel contain-
ing formaldehyde and blotted onto positively charged nylon mem-
brane. Samples are biliary atresia tissues obatined from liver trans-
plantation recipients (lanes 1 to 4, around 1 yr of age), biliary atre-
sia from wedge biopsy during Kasai operation (lane 5, around 10
weeks of age), normal liver tissues from liver transplantation donors
(lanes 6 and 7), and normal portion of hepatocellular carcinoma
liver tissue during hepatectomy (lane 8).
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patterns of diseased tissues with counterpart normal tissues
enables finding specific gene function. So, it is important to
analyze the changes of gene expression in developmental or
pathologic tissues or cells, in order to make clear the functions
of these genes. Furtheremore, it is mandatory to develop a
technique that can analyze a large number of genes simulta-
neously. Current methods to distinguish mRNA in compar-
ative studies rely largely on subtractive hybridization and dif-
ferential hybridization (5, 6). However, these techniques are
rather difficult to establish, and require large amounts of
RNA so that they are inappropriate for weakly expressed genes
in tissues. 
With the differential EST screening (DES) method like as
DNA chip analysis, many genes can be analyzed simultane-
ously and interrelationships of gene expression and function-
al or developmental phenomena can be determined. Relative-
ly small amounts of RNA are necessary so that the method
is ideally suited for measurement of gene expression in time
course experiments, in studies of development, or when the
amount of tissue is very limited or the sample size is small.
Typically a 10  g total RNA reaction yields sufficient radioac-
tivity to probe more than 400 genes. The most important
advantages of this method are that the identities of the spots
on the filter are known in advance and that differential hybrid-
ization clones are readily available for use in further character-
ization.
In this study, we found 28 differently expressed genes in
biliary cirrhosis due to biliary atresia by DES using a dot blot
panel of 1,730 different EST clones which had been isolated
from a human hair stromal cell cDNA library constructed by
the Department of Immunology at Kyungpook National
University School of Medicine. Twenty six cDNA clones were
significantly overexpressed in biliary cirrhosis due to biliary
atresia and were classified as genes associated with hepatic
fibrosis and genes with unclear roles. 
Genes known to be associated with hepatic fibrosis were
as follow: TGF- 1 (7-9), TIMP-1 (10, 11), lysyl oxidase,
collagen type I 1, 2, collagen type III (7), laminin, laminin
binding protein, fibronectin, osteonectin, HRS, IGFBP-2, -3
(2, 12), MLC kinase, thymosin  -4, -10, and pentaxin 3.
Genes with unclear roles in biliary atresia were bcl-w, SRP-
4,-9, SNAP 45, Alu RNA binding protein, supt5h, eIF-2
kinase, HSP 27, aldolase, and  -glutamylcysteine synthetase.
The mechanisms responsible for increased collagen produc-
tion and hepatic fibrosis in biliary atresia are unknown. Dur-
ing liver injury, hepatic stellate cells (HSCs) proliferate and
transform to fibrogenic myofibroblasts. In early injury, col-
lagen types III , V, and fibronectin accumulate, but in chron-
ic injury there is an increasing deposition of collagen types
I, IV, undulin, elastin, and laminin. HSC activation is regu-
lated by a wide variety of growth factors and cytokines derived
from other liver cells or from HSCs themselves. TGF- 1 upre-
gulates HSC expression of collagens type I, III, and IV, fibro-
nectin, and laminin (7). 
By definition, progressive fibrosis occurs when the rate of
matrix synthesis exceeds that of matrix degradation. A recent
work suggests that the HSCs are also a source of matrix de-
grading metalloproteinase (MMPs), indicating that, togeth-
er with other cells, HSCs could participate in matrix remod-
eling. In the early phases of their cellular activation, HSCs
release MMPs with the ability to degrade the normal liver
matrix. When HSCs are fully activated, there is a net down-
regulation of matrix degradation mediated by increased syn-
thesis and extracellular release of tissue inhibitors of metal-
loproteinase (TIMP)-1 and -2, which are powerful MMP
inhibitors. TIMP-1 and -2 may therefore promote progres-
sion of hepatic fibrosis through inhibition of matrix degra-
dation. In this  activated'phenotype the HSCs are the major
source of the interstitial collagens, which characterize fibro-
sis (10, 11, 13, 14). 
The liver plays a central role in the IGF-I axis producing
the majority of circulating hormones and some of its bind-
ing proteins (IGFBPs). Cirrhosis of the liver is characterized
by changes in IGF-I, which is known to regulate the action
of growth hormone, and IGFBPs associated with liver fibro-
sis and regeneration (12). The IGFs are present in the circu-
lation and throughout the extracellular space almost entire-
ly bound to members of a family of high-affinity IGF-bind-
ing proteins, six of which have been identified as IGFBP-1
to -6 that are essential to coordinate and regulate the biolog-
ical functions of the IGFs (4, 15). Holt et al. concluded that
hepatic gene expression of IGF-I are reduced in pediatric liver
disease. IGFBP-2 mRNA expression was increased, but there
were no changes in hepatic gene expression of IGFBP-1 and
-3 between biliary atresia and normal liver (4). In the study
of Ross et al., IGFBP-2 and IGFBP-3 tended to be more
highly expressed in cirrhotic liver and IGFBP-1 was more
highly expressed in normal liver. Although they studied the
concentration of serum IGF-BP as a prognostic factor of hep-
atoportoenterostomy, the results were not consistent (12).
We think that DES is a useful method for analyzing gene
expression patterns simultaneously, because we could ascertain
many genes involved in the process of hepatic fibrosis. The
results of TIMP-1 and IGFBP-2 were well correlated between
DES and northern blot analysis.
Among overexpressed genes in biliary atresia, genes not
known to be associated with hepatic fibrosis were bcl-w, HSP
27, SRP-4, -9, SNAP 45 and eIF-2 kinase. These genes
are known to be increased when there is cell destruction, pro-
duction or increase of cellular metabolism. Since the associa-
tion of hepatic fibrosis and biliary atresia with these genes is
not clear yet, we think that further studies about the func-
tion of these genes in biliary atresia should be conducted. Two
underexpressed genes in biliary atresia are similar genes of
gastrular zinc finger protein identified in Caenorhabditis elegans
and one unknown novel gene. Since there may be a possibility
that important regulatory factors are structurally or func-
tionally affected at a certain time point of their development,396 B.H. Choe, K.M. Kim, S. Kwon, et al.
we think that genes expressed in normal liver tissues but not
in pathologic liver tissues may have more important mean-
ings in identifying the cause of biliary atresia. 
Though we have used resected liver tissues instead of puri-
fying biliary epithelial cells from the removed livers in this
experiment, we believe that using a monoclonal antibody
(HEA125) for isolating biliary epithelial cells is required in
order to find genes specifically expressed in biliary atresia (16).
Furthermore, we can use human liver specific cDNA chip
to get more information about change in gene expression in
biliary atresia and we may be able to predict the severity of
disease in patients in whom portoenterostomy was not done
or unsuccessful and to determine the optimal time for liver
transplantation.
This study identified 28 differentially expressed genes in
the biliary cirrhosis from progressive biliary atresia using DES
technique. Searching for the genes involved in hepatic fibro-
sis itself may not be so helpful in finding the etiology of bil-
iary atresia. However, it may be helpful in researching the
prevention of hepatic fibrosis, early diagnosis of biliary atre-
sia, and predicting prognosis after hepatoportoenterostomy.
We believe this study can lead to a better understanding of
the pathogenesis of biliary atresia and hepatic fibrosis and
contribute to the development of an early diagnostic kit of
biliary atresia and discovery of therapeutic and preventive
agents against liver cirrhosis.
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